Location History:
- Cupertino, CA (US) (2009 - 2021)
- Palo Alto, CA (US) (2020 - 2022)
Company Filing History:
9 out of 70 
5 out of 92 
4 out of 9 
Years Active: 2009-2022
Title: Xianfeng Li: A Pioneering Innovator in Medical Science
Introduction:
In the world of innovation and patents, there are individuals who dedicate their lives to pushing the boundaries of what is possible. Xianfeng Li, hailing from Cupertino, CA, is one such visionary. With an impressive collection of 15 patents to his name, Li has made significant contributions to the field of medical science. This article sheds light on his latest patents, career highlights, collaborations, and the impact of his work.
Latest Patents:
Among Xianfeng Li's recent noteworthy patents are "4-substituted benzoxaborole compounds and uses thereof" and "Boron-containing small molecules." The former patent encompasses substituted benzoxaboroles, which have shown promise as anti-mycobacterial agents for treating mycobacterial infections in mammals. The latter patent highlights the use of benzoxaborole compounds for combating bacterial infections.
Career Highlights:
Li's contributions to the field of pharmaceuticals have spanned several reputable companies. He has worked at Anacor Pharmaceuticals, Inc., where he likely played a crucial role in their groundbreaking discoveries. Additionally, Li contributed his expertise to Glaxosmithkline Intellectual Property (No. 2) Limited, a key player in the pharmaceutical industry. Through his work at these establishments, Li has left an indelible mark on the field of medical science.
Collaborations:
Collaboration is often the fuel behind groundbreaking innovations. Two individuals who have had the privilege of working alongside Xianfeng Li are Vincent S Hernandez and Jacob J Plattner. With their combined expertise, the trio has likely contributed to the development of cutting-edge pharmaceutical solutions. These collaborations have undoubtedly played a vital role in the progress achieved by Li in his career.
Conclusion:
Xianfeng Li's expertise and dedication to the field of medical science have resulted in an impressive portfolio of 15 patents. His groundbreaking work in developing novel substituted benzoxaboroles and boron-containing small molecules has the potential to revolutionize the treatment of mycobacterial and bacterial infections. Li's career highlights and collaborations further emphasize his role as a pioneering innovator in the pharmaceutical industry. With each patent, he redefines possibilities within the medical science realm, leaving behind a legacy of innovation and transforming healthcare outcomes for the better.